Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion

Purpose To evaluate the efficacy and safety of sequential therapy with ranibizumab followed by dexamethasone intravitreal implant compared with dexamethasone monotherapy for macular oedema (MO) secondary to retinal vein occlusion (RVO). Methods In this retrospective interventional study, the medical...

Descrición completa

Detalles Bibliográficos
Main Authors: Iu, L, Zhao, P, Yeung, I, Fung, N, Lee, J, Wong, R, Chong, V, Wong, I
Formato: Journal article
Idioma:English
Publicado: BMJ Publishing Group 2014

Títulos similares